Integrity Alliance LLC. acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 418 shares of the biotechnology company's stock, valued at approximately $220,000.
Several other hedge funds have also modified their holdings of the company. SageView Advisory Group LLC lifted its position in shares of Axon Enterprise by 11.2% during the first quarter. SageView Advisory Group LLC now owns 446 shares of the biotechnology company's stock valued at $235,000 after buying an additional 45 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Axon Enterprise by 4.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 555,690 shares of the biotechnology company's stock worth $292,265,000 after buying an additional 24,132 shares during the period. Woodline Partners LP increased its holdings in Axon Enterprise by 40.6% in the 1st quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company's stock worth $3,646,000 after buying an additional 2,003 shares during the period. Empowered Funds LLC boosted its position in Axon Enterprise by 8.4% in the 1st quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company's stock worth $1,067,000 after purchasing an additional 157 shares in the last quarter. Finally, MBB Public Markets I LLC purchased a new stake in Axon Enterprise in the 1st quarter worth approximately $294,000. 79.08% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
AXON has been the topic of a number of recent analyst reports. Craig Hallum upgraded Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 target price on the stock in a research report on Tuesday, August 5th. Wolfe Research initiated coverage on Axon Enterprise in a report on Monday, July 7th. They issued an "outperform" rating on the stock. Zacks Research lowered Axon Enterprise from a "strong-buy" rating to a "hold" rating in a report on Tuesday, September 2nd. Needham & Company LLC set a $870.00 price objective on Axon Enterprise and gave the company a "buy" rating in a report on Tuesday, August 5th. Finally, JPMorgan Chase & Co. raised their target price on Axon Enterprise from $730.00 to $850.00 and gave the stock an "overweight" rating in a research note on Thursday, July 17th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of "Moderate Buy" and a consensus price target of $837.69.
Read Our Latest Research Report on AXON
Axon Enterprise Stock Up 0.7%
Shares of NASDAQ:AXON opened at $756.13 on Monday. The business has a 50-day moving average price of $761.10 and a 200 day moving average price of $688.38. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The company has a market capitalization of $59.36 billion, a price-to-earnings ratio of 186.70, a PEG ratio of 27.75 and a beta of 1.40. Axon Enterprise, Inc has a 12-month low of $375.71 and a 12-month high of $885.91.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.54 by $0.58. The firm had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company's quarterly revenue was up 32.6% on a year-over-year basis. During the same period last year, the company earned $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. Sell-side analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current year.
Insider Buying and Selling
In other Axon Enterprise news, CAO Jennifer H. Mak sold 75 shares of Axon Enterprise stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $723.50, for a total value of $54,262.50. Following the completion of the transaction, the chief accounting officer directly owned 15,080 shares of the company's stock, valued at $10,910,380. The trade was a 0.49% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $743.64, for a total value of $7,436,400.00. Following the completion of the transaction, the chief executive officer directly owned 3,043,982 shares of the company's stock, valued at approximately $2,263,626,774.48. This represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 44,790 shares of company stock worth $34,304,947 over the last 90 days. 5.70% of the stock is owned by insiders.
Axon Enterprise Company Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.